Principal Financial Group’s Precision BioSciences DTIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-22,705
| Closed | -$2.1M | – | 2543 |
|
|
2022
Q1 | $2.1M | Sell |
22,705
-13
| -0.1% | -$1.2K | ﹤0.01% | 1856 |
|
|
2021
Q4 | $5.04M | Buy |
22,718
+6,408
| +39% | +$1.42M | ﹤0.01% | 1662 |
|
|
2021
Q3 | $5.65M | Buy |
16,310
+943
| +6% | +$326K | ﹤0.01% | 1639 |
|
|
2021
Q2 | $5.77M | Buy |
15,367
+1,404
| +10% | +$527K | ﹤0.01% | 1671 |
|
|
2021
Q1 | $4.34M | Buy |
13,963
+1,063
| +8% | +$330K | ﹤0.01% | 1704 |
|
|
2020
Q4 | $3.23M | Buy |
12,900
+563
| +5% | +$141K | ﹤0.01% | 1691 |
|
|
2020
Q3 | $2.28M | Buy |
12,337
+367
| +3% | +$67.8K | ﹤0.01% | 1711 |
|
|
2020
Q2 | $2.99M | Buy |
11,970
+4,303
| +56% | +$1.08M | ﹤0.01% | 1604 |
|
|
2020
Q1 | $1.39M | Hold |
7,667
| – | – | ﹤0.01% | 1682 |
|
|
2019
Q4 | $3.2M | Buy |
7,667
+2,017
| +36% | +$841K | ﹤0.01% | 1643 |
|
|
2019
Q3 | $1.42M | Buy |
5,650
+1,505
| +36% | +$379K | ﹤0.01% | 1776 |
|
|
2019
Q2 | $1.65M | Buy |
4,145
+1,645
| +66% | +$654K | ﹤0.01% | 1752 |
|
|
2019
Q1 | $1.35M | Buy |
+2,500
| New | +$1.35M | ﹤0.01% | 1791 |
|